Literature DB >> 8790416

Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.

I Connell1, W Agace, P Klemm, M Schembri, S Mărild, C Svanborg.   

Abstract

Type 1 fimbriae are adhesion organelles expressed by many Gram-negative bacteria. They facilitate adherence to mucosal surfaces and inflammatory cells in vitro, but their contribution to virulence has not been defined. This study presents evidence that type 1 fimbriae increase the virulence of Escherichia coli for the urinary tract by promoting bacterial persistence and enhancing the inflammatory response to infection. In a clinical study, we observed that disease severity was greater in children infected with E. coli O1:K1:H7 isolates expressing type 1 fimbriae than in those infected with type 1 negative isolates of the same serotype. The E. coli O1:K1:H7 isolates had the same electrophoretic type, were hemolysin-negative, expressed P fimbriae, and carried the fim DNA sequences. When tested in a mouse urinary tract infection model, the type 1-positive E. coli O1:K1:H7 isolates survived in higher numbers, and induced a greater neutrophil influx into the urine, than O1:K1:H7 type 1-negative isolates. To confirm a role of type 1 fimbriae, a fimH null mutant (CN1016) was constructed from an O1:K1:H7 type 1-positive parent. E. coli CN1016 had reduced survival and inflammatogenicity in the mouse urinary tract infection model. E. coli CN1016 reconstituted with type 1 fimbriae (E. coli CN1018) had restored virulence similar to that of the wild-type parent strain. These results show that type 1 fimbriae in the genetic background of a uropathogenic strain contribute to the pathogenesis of E. coli in the urinary tract.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8790416      PMCID: PMC38514          DOI: 10.1073/pnas.93.18.9827

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin.

Authors:  A E Wold; J Mestecky; M Tomana; A Kobata; H Ohbayashi; T Endo; C S Edén
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

2.  Mannose residues on phagocytes as receptors for the attachment of Escherichia coli and Salmonella typhi.

Authors:  Z Bar-Shavit; I Ofek; R Goldman; D Mirelman; N Sharon
Journal:  Biochem Biophys Res Commun       Date:  1977-09-09       Impact factor: 3.575

3.  Analysis of gene control signals by DNA fusion and cloning in Escherichia coli.

Authors:  M J Casadaban; S N Cohen
Journal:  J Mol Biol       Date:  1980-04       Impact factor: 5.469

4.  Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gram-negative bacteria.

Authors:  M Herrero; V de Lorenzo; K N Timmis
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

5.  Cloning of genes determining the production of mannose-resistant fimbriae in a uropathogenic strain of Escherichia coli belonging to serogroup O6.

Authors:  S Clegg
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

6.  Antipili antibody affords protection against experimental ascending pyelonephritis.

Authors:  F J Silverblatt; L S Cohen
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

7.  Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside.

Authors:  M Aronson; O Medalia; L Schori; D Mirelman; N Sharon; I Ofek
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

8.  Contribution of adhesion to bacterial persistence in the mouse urinary tract.

Authors:  L Hagberg; R Hull; S Hull; S Falkow; R Freter; C Svanborg Edén
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

9.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.

Authors:  L Hagberg; I Engberg; R Freter; J Lam; S Olling; C Svanborg Edén
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections.

Authors:  L Hagberg; U Jodal; T K Korhonen; G Lidin-Janson; U Lindberg; C Svanborg Edén
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

View more
  227 in total

1.  Type 1 fimbriation and phase switching in a natural Escherichia coli fimB null strain, Nissle 1917.

Authors:  B Stentebjerg-Olesen; T Chakraborty; P Klemm
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

2.  PapD-like chaperones provide the missing information for folding of pilin proteins.

Authors:  M M Barnhart; J S Pinkner; G E Soto; F G Sauer; S Langermann; G Waksman; C Frieden; S J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

3.  Snapshots of usher-mediated protein secretion and ordered pilus assembly.

Authors:  E T Saulino; E Bullitt; S J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

4.  Chaperone-subunit-usher interactions required for donor strand exchange during bacterial pilus assembly.

Authors:  Michelle M Barnhart; Frederic G Sauer; Jerome S Pinkner; Scott J Hultgren
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

5.  Vaccine Development for the Prevention of Urinary Tract Infections.

Authors:  Walter J. Hopkins; David T. Uehling
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.725

6.  Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Corinne K Cusumano; Thomas J Hannan; James W Janetka; Scott J Hultgren
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

7.  Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.

Authors:  K Thankavel; B Madison; T Ikeda; R Malaviya; A H Shah; P M Arumugam; S N Abraham
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

8.  Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection.

Authors:  T Asahara; K Nomoto; M Watanuki; T Yokokura
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

9.  Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073.

Authors:  Luke P Allsopp; Christophe Beloin; Glen C Ulett; Jaione Valle; Makrina Totsika; Orla Sherlock; Jean-Marc Ghigo; Mark A Schembri
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 10.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.